Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Temperature Controlled Packaging Pharmaceutical Market

ID: MRFR/PCM/11432-HCR
100 Pages
Garvit Vyas
Last Updated: April 24, 2026
US Temperature Controlled Packaging for Pharmaceutical Market Research Report Information By Product (Insulated Shippers, and Insulated Containers), By Type (Active Systems, and Passive Systems), By Temperature Range (Up to 10 C, 10 C to 20 C, and More than 20 C), By End-Use Industry (Pharmaceutical, and Clinical Trail), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Packaging & Transport, BY Product (USD Million)
      1. 4.1.1 Shippers
      2. 4.1.2 Containers
    2. 4.2 Packaging & Transport, BY Type (USD Million)
      1. 4.2.1 Active System
      2. 4.2.2 Passive System
    3. 4.3 Packaging & Transport, BY Temperature Range (USD Million)
      1. 4.3.1 -20°C and Below
      2. 4.3.2 -20°C to 0°C
      3. 4.3.3 2°C to 8°C
      4. 4.3.4 8°C to 25°C
      5. 4.3.5 Above 25°C
    4. 4.4 Packaging & Transport, BY Payload Capacity (USD Million)
      1. 4.4.1 Up to 10 L
      2. 4.4.2 10 L - 20 L
      3. 4.4.3 20 L - 40 L
      4. 4.4.4 40 L - 150 L
      5. 4.4.5 Above 150 L
    5. 4.5 Packaging & Transport, BY Use (USD Million)
      1. 4.5.1 Single Use
      2. 4.5.2 Reusable
    6. 4.6 Packaging & Transport, BY Medicine Type (USD Million)
      1. 4.6.1 Temperature Sensitive Pharmaceutical Drugs
      2. 4.6.2 Vaccine
      3. 4.6.3 Regenerative Medicine
    7. 4.7 Packaging & Transport, BY End-use Industry (USD Million)
      1. 4.7.1 Pharmaceuticals
      2. 4.7.2 Clinical Trials
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Packaging & Transport
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Packaging & Transport
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Thermo Fisher Scientific (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Sonoco Products Company (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Pelican BioThermal (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 CSafe Global (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Cold Chain Technologies (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 DHL Supply Chain (DE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Envirotainer (SE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Sofrigam (FR)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY PRODUCT
    3. 6.3 US MARKET ANALYSIS BY TYPE
    4. 6.4 US MARKET ANALYSIS BY TEMPERATURE RANGE
    5. 6.5 US MARKET ANALYSIS BY PAYLOAD CAPACITY
    6. 6.6 US MARKET ANALYSIS BY USE
    7. 6.7 US MARKET ANALYSIS BY MEDICINE TYPE
    8. 6.8 US MARKET ANALYSIS BY END-USE INDUSTRY
    9. 6.9 KEY BUYING CRITERIA OF PACKAGING & TRANSPORT
    10. 6.10 RESEARCH PROCESS OF MRFR
    11. 6.11 DRO ANALYSIS OF PACKAGING & TRANSPORT
    12. 6.12 DRIVERS IMPACT ANALYSIS: PACKAGING & TRANSPORT
    13. 6.13 RESTRAINTS IMPACT ANALYSIS: PACKAGING & TRANSPORT
    14. 6.14 SUPPLY / VALUE CHAIN: PACKAGING & TRANSPORT
    15. 6.15 PACKAGING & TRANSPORT, BY PRODUCT, 2024 (% SHARE)
    16. 6.16 PACKAGING & TRANSPORT, BY PRODUCT, 2024 TO 2035 (USD Million)
    17. 6.17 PACKAGING & TRANSPORT, BY TYPE, 2024 (% SHARE)
    18. 6.18 PACKAGING & TRANSPORT, BY TYPE, 2024 TO 2035 (USD Million)
    19. 6.19 PACKAGING & TRANSPORT, BY TEMPERATURE RANGE, 2024 (% SHARE)
    20. 6.20 PACKAGING & TRANSPORT, BY TEMPERATURE RANGE, 2024 TO 2035 (USD Million)
    21. 6.21 PACKAGING & TRANSPORT, BY PAYLOAD CAPACITY, 2024 (% SHARE)
    22. 6.22 PACKAGING & TRANSPORT, BY PAYLOAD CAPACITY, 2024 TO 2035 (USD Million)
    23. 6.23 PACKAGING & TRANSPORT, BY USE, 2024 (% SHARE)
    24. 6.24 PACKAGING & TRANSPORT, BY USE, 2024 TO 2035 (USD Million)
    25. 6.25 PACKAGING & TRANSPORT, BY MEDICINE TYPE, 2024 (% SHARE)
    26. 6.26 PACKAGING & TRANSPORT, BY MEDICINE TYPE, 2024 TO 2035 (USD Million)
    27. 6.27 PACKAGING & TRANSPORT, BY END-USE INDUSTRY, 2024 (% SHARE)
    28. 6.28 PACKAGING & TRANSPORT, BY END-USE INDUSTRY, 2024 TO 2035 (USD Million)
    29. 6.29 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT, 2025-2035 (USD Million)
      2. 7.2.2 BY TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY TEMPERATURE RANGE, 2025-2035 (USD Million)
      4. 7.2.4 BY PAYLOAD CAPACITY, 2025-2035 (USD Million)
      5. 7.2.5 BY USE, 2025-2035 (USD Million)
      6. 7.2.6 BY MEDICINE TYPE, 2025-2035 (USD Million)
      7. 7.2.7 BY END-USE INDUSTRY, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Packaging & Transport Market Segmentation

Packaging & Transport By Product (USD Million, 2025-2035)

  • Shippers
  • Containers

Packaging & Transport By Type (USD Million, 2025-2035)

  • Active System
  • Passive System

Packaging & Transport By Temperature Range (USD Million, 2025-2035)

  • -20°C and Below
  • -20°C to 0°C
  • 2°C to 8°C
  • 8°C to 25°C
  • Above 25°C

Packaging & Transport By Payload Capacity (USD Million, 2025-2035)

  • Up to 10 L
  • 10 L - 20 L
  • 20 L - 40 L
  • 40 L - 150 L
  • Above 150 L

Packaging & Transport By Use (USD Million, 2025-2035)

  • Single Use
  • Reusable

Packaging & Transport By Medicine Type (USD Million, 2025-2035)

  • Temperature Sensitive Pharmaceutical Drugs
  • Vaccine
  • Regenerative Medicine

Packaging & Transport By End-use Industry (USD Million, 2025-2035)

  • Pharmaceuticals
  • Clinical Trials